RTP gene editing startup Locus Biosciences lands $12.5M from 31 investors

The round, which kicked off on April 8, is capped at $15 million, with $2.5 million remaining to be sold. Funds raised will be used fo “payments of salary in the ordinary course of business,” the filing indicated.